Ascendis Pharma A earnings were -$393.8M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ASND earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$40.1M, down 63.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ASND reported annual earnings of -$393.8M, with -26.4% growth. The next ASND earnings date is Apr 30, 2025.
What were Ascendis Pharma A's earnings last quarter?
Ascendis Pharma A (NASDAQ: ASND) reported Q4 2024 earnings per share (EPS) of -$0.63, up 63.24% year over year. Total ASND earnings for the quarter were -$40.07 million. In the same quarter last year, Ascendis Pharma A's earnings per share (EPS) was -$1.70.
The next ASND earnings call is Invalid Date. Add ASND to your watchlist to be reminded of Ascendis Pharma A's next earnings date.
What was ASND's earnings growth in the past year?
As of Ascendis Pharma A's earnings date in Q2 2025, Ascendis Pharma A's earnings has grown year over year. ASND earnings in the past year totalled -$393.84 million.
Is Ascendis Pharma A profitable or losing money?
As of the last Ascendis Pharma A earnings report, Ascendis Pharma A is currently losing money. Ascendis Pharma A's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$393.84 million, a 26.38% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.